Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Acute Kidney Injury in Emergency Medical Admissions.
Athanasios FeidakisMaria-Rosa PanagiotouEmmanouil TsoukakisDimitra BacharakiParaskevi GounariPetros NikolopoulosKaterina P MarathiasSophia LionakiDemetrios VlahakosPublished in: Journal of clinical medicine (2021)
The risk of AKI in emergency medical admissions is higher among users of ACEIs/ARB at target or above target dosages. Physicians should adjust RAS blockade according to estimated Glomerular Filtration Rate (eGFR) and advise their patients to withhold ACEi/ARB in cases of acute illness.
Keyphrases
- angiotensin converting enzyme
- emergency medical
- angiotensin ii
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- primary care
- peritoneal dialysis
- prognostic factors
- tyrosine kinase
- respiratory failure
- intensive care unit
- patient reported
- aortic dissection
- mechanical ventilation
- wild type